No Surprises Act and IDR in 2026: What Providers Win, What Changed, and How to Recover More
The process for recovering IDR revenue is simple; there is only one rule: Don’t dispute every claim; dispute the right claims and document each case like your payment depends on it, because it does. Providers win about 85 to 88% of arbitration cases under the No Surprises Act. That success has grown to a mind-boggling projected payout of $15 billion in 2025, three times the amount earned the year before.
How the No Surprises Act got here: 2022 to 2026
Why the No Surprises Act quietly drains out-of-network revenue
Every dispute turns on one number: the Qualifying Payment Amount, or QPA. It is the insurer's own median in-network rate. Payers anchor their first out-of-network offer to the QPA, and that offer usually sits well below your billed charges.
The trap is quiet. A busy, understaffed revenue cycle team sees a low offer, decides the fight is not worth the effort, and posts the payment. One claim at a time, that looks reasonable. Across a full book of out-of-network claims, it becomes a standing write-off, the kind that shows up in a missed budget rather than a single missed claim.
Not every dispute is worth filing: a simple way to triage
This is where most teams go wrong, in both directions. Some file nothing. Others file everything and burn fees on cases they were never going to win. A better approach sorts every eligible claim by three factors before a single dollar is spent.
Eligibility - Is the claim actually subject to federal IDR, or does it fall under a state process, a self-funded plan, or a program like Medicare or Medicaid? Filing an ineligible dispute wastes both the fee and your team's time.
The size of the QPA gap - A small gap between the offer and fair reimbursement rarely justifies the effort. A large gap is where recovery lives.
The strength of your evidence - IDR is decided on the case file. If you can back up your number with payment history and comparable rates, the odds are in your favor. If you cannot, the dispute is closer to a coin flip.
Categorize the claims like this, and you will see that there emerges a clear distinction between claims worth pursuing through arbitration, claims worth negotiating quickly, and claims not worth pursuing at all. It is not the volume of claims but their selection that determines the winning rate.
What the numbers do not tell you
The headline win rates are encouraging, but they deserve context, and honesty here matters more than a clean sales pitch.
First, the win rate is an average, not a promise. When providers do win, awards tend to land above the insurer's benchmark, exceeding the QPA in about 87% of determinations. Still, that figure reflects the mix of disputes providers have chosen to file, many of them well selected. A poorly chosen dispute does not inherit that average.
Second, the ground is still moving. The method for calculating the QPA has been challenged in court and remains unsettled after the Texas Medical Association litigation. The number at the center of every dispute is itself contested.
Third, filing is not risk-free. Insurers challenge a meaningful share of disputes as ineligible, and a rejected filing costs you the fee and the time. This is exactly why selection comes first.
None of this is an argument against IDR. It is an argument for doing it deliberately.
Best practices for IDR revenue recovery
A few principles hold up across payers and specialties.
- File only eligible disputes - Confirm federal versus state jurisdiction and plan type before you spend the fee. Eligibility screening is the cheapest step and the one most often skipped.
- Anchor the process on the QPA difference, not the billed amount - You have the strongest case when you present a well-justified case for reimbursement, not just an appeal based on your list price.
- Create the documentation package before the deadline arrives, not after - The IDR clock is ticking. Start collecting information and preparing documents for each claim as soon as it comes in, so you're ready the moment the clock starts.
- Evaluate viability with an expert before you file - An initial review with an expert about the viability of your case saves you money and your reputation.
Track outcomes by payer. Every determination teaches you something about how a given payer behaves. Feed that intelligence back into your next round of filings.
A real result: recovering fair pay for an anesthesia group
A four-practice anesthesia group was being reimbursed far below billed charges on out-of-network claims, with underpayments spread across several major national payers. Working claim by claim through the No Surprises Act, Plutus Health turned $47,330 in initial payer payments into $298,573 in accepted offers across 44 claims, recovering $251,243 above what the payers first paid.
What is changing in 2026, and the deadline you cannot miss
In May 2026, regulators finalized the largest overhaul of the process since launch. A few changes matter for every revenue leader.
- The filing fee dropped. The per-party administrative fee fell from $115 to $15, which lowers the cost of pursuing legitimate disputes.
- A central IDR Gateway is coming. A new portal launches in late 2026 to initiate and track disputes in one place, with payers required to register.
- New remittance codes arrive November 1, 2026. Plans will flag on the remittance whether a service is subject to IDR. Your billing workflow needs to read and act on these codes.
- Eligibility screening is getting stricter. Cheaper filing plus tighter gatekeeping means the advantage shifts further toward teams that select and document well.
The takeaway is clear and profitable. Pursuing disputes isn’t the plan, but filing them correctly matters more. The teams that prepare before the November deadline will be the ones collecting in 2027.
How a disciplined IDR process actually runs
The organizations that win treat IDR as a repeatable operating model, not a scramble. In practice, it looks like six steps.
- Identify every NSA-eligible claim and track its deadlines.
- Analyze the offer against QPA benchmarks and pricing data to find undervaluation early.
- Build an arbitration-ready case: payment history, comparable rates, clinical records, compliance documentation.
- Validate each dispute with specialist and legal review before submission.
- Manage the negotiation, arbitrator selection, and every filing deadline.
- Measure outcomes and feed payer intelligence back into future filings.
This is where technology earns its place, scoring each dispute based on payer history, QPA variance, specialty, and past outcomes, so that effort goes where recovery is most likely. It is the model we run at Plutus Health for out-of-network-heavy specialties such as ER and ASC, pairing automated eligibility and QPA analytics with experienced IDR specialists who make the final call.
With millions recovered in NSA and IDR disputes and a track record against major payers, Plutus Health runs the entire process end-to-end, from eligibility checks to arbitration, so your team can stay focused on patient care.





















































